95 related articles for article (PubMed ID: 1757154)
1. Using ultrapure water in hemodialysis delays carpal tunnel syndrome.
Baz M; Durand C; Ragon A; Jaber K; Andrieu D; Merzouk T; Purgus R; Olmer M; Reynier JP; Berland Y
Int J Artif Organs; 1991 Nov; 14(11):681-5. PubMed ID: 1757154
[TBL] [Abstract][Full Text] [Related]
2. Conventional versus ultrapure dialysate for lowering serum lipoprotein(a) levels in patients on long-term hemodialysis: a randomized trial.
Tao J; Sun Y; Li X; Li H; Liu S; Wen Y; Duan L; Li Y; Li X
Int J Artif Organs; 2010 May; 33(5):290-6. PubMed ID: 20593350
[TBL] [Abstract][Full Text] [Related]
3. Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes.
Campistol JM; Torregrosa JV; Ponz E; Fenollosa B
Contrib Nephrol; 1999; 125():76-85. PubMed ID: 9895432
[No Abstract] [Full Text] [Related]
4. Carpal tunnel syndrome and plasma beta2-microglobulin concentration in hemodialysis patients.
Shin J; Nishioka M; Shinko S; Shibuya K; Sugiki M; Kasumoto H; Fudo A; Bito Y; Fujita Y; Komaba K
Ther Apher Dial; 2008 Feb; 12(1):62-6. PubMed ID: 18257814
[TBL] [Abstract][Full Text] [Related]
5. Carpal tunnel syndrome: a major complication in hemodialysis patients.
Sivri A; Celiker R; Sungur C; Kutsal YG
Scand J Rheumatol; 1994; 23(5):287-90. PubMed ID: 7973484
[TBL] [Abstract][Full Text] [Related]
6. Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach.
Cianciolo G; Colí L; La Manna G; Donati G; D'Addio F; Comai G; Ricci D; Dormi A; Wratten M; Feliciangeli G; Stefoni S
Int J Artif Organs; 2007 Oct; 30(10):864-78. PubMed ID: 17992647
[TBL] [Abstract][Full Text] [Related]
7. Behavior of beta 2-microglobulin (B2-m) serum levels in uremic patients.
Mioli VA; Balestra E; Bibiano L; Dellabella S; Fanciulli E; Gaffi G; Perilli A; Petroselli F; Ricciatti AM; Carletti P
Int J Artif Organs; 1994 Nov; 17(11):576-80. PubMed ID: 7744516
[TBL] [Abstract][Full Text] [Related]
8. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
9. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients.
Furuya R; Kumagai H; Takahashi M; Sano K; Hishida A
Blood Purif; 2005; 23(4):311-6. PubMed ID: 15980621
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products and β(2)-microglobulin as predictors of carpal tunnel syndrome in hemodialysis patients.
Busch M; Schwenzky A; Franke S; Stein G; Wolf G
Blood Purif; 2012; 34(1):3-9. PubMed ID: 22699860
[TBL] [Abstract][Full Text] [Related]
11. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients.
Koda Y; Nishi S; Miyazaki S; Haginoshita S; Sakurabayashi T; Suzuki M; Sakai S; Yuasa Y; Hirasawa Y; Nishi T
Kidney Int; 1997 Oct; 52(4):1096-101. PubMed ID: 9328951
[TBL] [Abstract][Full Text] [Related]
12. Learning from the Japanese Registry: how will we prevent long-term complications? Niigata Research Programme for beta 2-M Removal Membrane.
Aoike I; Gejyo F; Arakawa M
Nephrol Dial Transplant; 1995; 10 Suppl 7():7-15. PubMed ID: 8570083
[TBL] [Abstract][Full Text] [Related]
13. Histopathology and clinical results of carpal tunnel syndrome in idiopathic cases and hemodialysis patients.
Kinugasa K; Hashizume H; Nishida K; Shigeyama Y; Inoue H
Acta Med Okayama; 1997 Apr; 51(2):63-70. PubMed ID: 9142342
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonographic evaluation of the carpal tunnel syndrome in hemodialysis patients.
Ikegaya N; Hishida A; Sawada K; Furuhashi M; Maruyama Y; Kumagai H; Kobayashi S; Yamamoto T; Yamazaki K
Clin Nephrol; 1995 Oct; 44(4):231-7. PubMed ID: 8575122
[TBL] [Abstract][Full Text] [Related]
15. Carpal tunnel syndrome: a major complication in long-term hemodialysis patients.
Schwarz A; Keller F; Seyfert S; Pöll W; Molzahn M; Distler A
Clin Nephrol; 1984 Sep; 22(3):133-7. PubMed ID: 6488595
[TBL] [Abstract][Full Text] [Related]
16. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients.
Schiffl H
Hemodial Int; 2014 Jan; 18(1):136-41. PubMed ID: 23718290
[TBL] [Abstract][Full Text] [Related]
17. Blood lead level: an overlooked risk of carpal tunnel syndrome in hemodialysis patients.
Huang WH; Hu CC; Yen TH; Hsu CW; Weng CH
Ren Fail; 2019 Nov; 41(1):786-793. PubMed ID: 31498017
[No Abstract] [Full Text] [Related]
18. [Carpal tunnel syndrome associated with long-term hemodialysis: case report].
Suwa H; Hanakita J; Sakaida H; Nishi S; Ohta F; Mori N; Nagamine T; Taniyama K
No Shinkei Geka; 1989 Aug; 17(8):747-50. PubMed ID: 2685635
[TBL] [Abstract][Full Text] [Related]
19. Ultrapure dialysate and inflammatory response in haemodialysis evaluated by darbepoetin requirements--a randomized study.
Lamas JM; Alonso M; Sastre F; García-Trío G; Saavedra J; Palomares L
Nephrol Dial Transplant; 2006 Oct; 21(10):2851-8. PubMed ID: 16822792
[TBL] [Abstract][Full Text] [Related]
20. Effect of dialysate buffer on serum beta-2-microglobulin levels in chronic hemodialysis.
Küchle C; Lang SM; Schiffl H
Nephron; 1998; 79(1):99-100. PubMed ID: 9609469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
